Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocugen (OCGN) EBIT (2016 - 2025)

Historic EBIT for Ocugen (OCGN) over the last 12 years, with Q3 2025 value amounting to -$17.6 million.

  • Ocugen's EBIT fell 3299.88% to -$17.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$59.8 million, marking a year-over-year decrease of 1395.64%. This contributed to the annual value of -$54.8 million for FY2024, which is 1644.11% up from last year.
  • Latest data reveals that Ocugen reported EBIT of -$17.6 million as of Q3 2025, which was down 3299.88% from -$13.8 million recorded in Q2 2025.
  • Ocugen's 5-year EBIT high stood at -$7.1 million for Q1 2021, and its period low was -$25.6 million during Q2 2021.
  • In the last 5 years, Ocugen's EBIT had a median value of -$14.6 million in 2021 and averaged -$16.5 million.
  • In the last 5 years, Ocugen's EBIT tumbled by 66084.37% in 2021 and then surged by 5065.3% in 2023.
  • Quarter analysis of 5 years shows Ocugen's EBIT stood at -$14.6 million in 2021, then crashed by 60.27% to -$23.4 million in 2022, then soared by 50.65% to -$11.5 million in 2023, then decreased by 20.09% to -$13.8 million in 2024, then fell by 27.35% to -$17.6 million in 2025.
  • Its EBIT was -$17.6 million in Q3 2025, compared to -$13.8 million in Q2 2025 and -$14.5 million in Q1 2025.